David Ross Parkinson is Chief Executive Officer of ESSA Pharma Inc.. Currently has a direct ownership of 65,675 shares of EPIX, which is worth approximately $107,707. The most recent transaction as insider was on Dec 14, 2023, when has been sold 9,223 shares (Common Shares) at a price of $2.3 per share, resulting in proceeds of $21,212. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.7K
0% 3M change
0% 12M change
Total Value Held $107,707

David Ross Parkinson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
BUY
Open market or private purchase
$21,212 $2.3 p/Share
9,223 Added 12.31%
65,675 Common Shares
Dec 30 2022
BUY
Open market or private purchase
$7,974 $2.6 p/Share
3,067 Added 5.15%
56,542 Common Shares
Dec 22 2022
BUY
Open market or private purchase
$51,067 $2.39 p/Share
21,367 Added 28.55%
53,475 Common Shares
Jun 30 2022
BUY
Open market or private purchase
$14,466 $2.96 p/Share
4,887 Added 13.21%
32,108 Common Shares

Also insider at

CTIC
CTI BIOPHARMA CORP Healthcare
DRP

David Ross Parkinson

Chief Executive Officer
Vancouver, A1

Track Institutional and Insider Activities on EPIX

Follow ESSA Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPIX shares.

Notify only if

Insider Trading

Get notified when an Essa Pharma Inc. insider buys or sells EPIX shares.

Notify only if

News

Receive news related to ESSA Pharma Inc.

Track Activities on EPIX